|
|
|
|
|
|
|
|
|
carbamates |
|
|
|
|
|
|
|
|
|
|
|
ccr5 co.receptor antagonists |
|
|
|
chloride channel activators |
|
|
|
|
|
|
|
cholinesterase reactivators |
|
complement.inhibitors |
|
|
|
calcium channel blockers (dihydropyridine) |
|
carbohydrates |
|
CD4-directed post-attachment HIV-1 inhibitor |
|
cholinergics, muscarinic agonists, sialagogues |
|
cholinergics (cholinesterase inhibitors), n methyl d aspartate antagonist |
|
colloids |
|
complement.inhibitors, monoclonal antibodies |
|
|
|
corticosteroids, long-acting beta2-adrenergic agonists (LABAs), anticholinergics |
|
|
|
corticosteroids (topical) |
